Baxalta (Minnesota biologics manufacturing facility) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Baxalta (Minnesota biologics manufacturing facility) General Information

Description

Developer of drugs. The company is engaged in development and discovery of drugs, therapy cures, medicines and other biologic products

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Brooklyn Park, MN
  • United States
Primary Industry
Drug Discovery
Acquirer
Takeda Pharmaceutical
Corporate Office
  • Brooklyn Park, MN
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baxalta (Minnesota biologics manufacturing facility) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Baxalta (Minnesota biologics manufacturing facility)‘s full profile, request access.

Request a free trial

Baxalta (Minnesota biologics manufacturing facility) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Baxalta (Minnesota biologics manufacturing facility)‘s full profile, request access.

Request a free trial

Baxalta (Minnesota biologics manufacturing facility) FAQs

  • Where is Baxalta (Minnesota biologics manufacturing facility) headquartered?

    Baxalta (Minnesota biologics manufacturing facility) is headquartered in Brooklyn Park, MN.

  • What industry is Baxalta (Minnesota biologics manufacturing facility) in?

    Baxalta (Minnesota biologics manufacturing facility)’s primary industry is Drug Discovery.

  • Is Baxalta (Minnesota biologics manufacturing facility) a private or public company?

    Baxalta (Minnesota biologics manufacturing facility) is a Private company.

  • What is Baxalta (Minnesota biologics manufacturing facility)’s current revenue?

    The current revenue for Baxalta (Minnesota biologics manufacturing facility) is .

  • Who are Baxalta (Minnesota biologics manufacturing facility)’s investors?

    Baxalta has invested in Baxalta (Minnesota biologics manufacturing facility).

  • When was Baxalta (Minnesota biologics manufacturing facility) acquired?

    Baxalta (Minnesota biologics manufacturing facility) was acquired on 05-Jan-2016.

  • Who acquired Baxalta (Minnesota biologics manufacturing facility)?

    Baxalta (Minnesota biologics manufacturing facility) was acquired by Takeda Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »